| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDHR2 OBSCN ITGA2 ITGA4 ITGA7 ITGB4 TENM2 DSCAML1 FAP PTPN6 NRXN2 PTPRM NOS3 IDH1 TENM4 TENM3 TLN1 KIRREL1 CDH18 | 4.75e-06 | 599 | 190 | 19 | GO:0050839 |
| GeneOntologyMolecularFunction | natural killer cell lectin-like receptor binding | 1.72e-05 | 17 | 190 | 4 | GO:0046703 | |
| GeneOntologyMolecularFunction | CD8 receptor binding | 6.83e-05 | 9 | 190 | 3 | GO:0042610 | |
| GeneOntologyMolecularFunction | TAP complex binding | 6.83e-05 | 9 | 190 | 3 | GO:0062061 | |
| GeneOntologyMolecularFunction | TAP1 binding | 9.69e-05 | 10 | 190 | 3 | GO:0046978 | |
| GeneOntologyMolecularFunction | TAP2 binding | 9.69e-05 | 10 | 190 | 3 | GO:0046979 | |
| GeneOntologyMolecularFunction | TAP binding | 9.69e-05 | 10 | 190 | 3 | GO:0046977 | |
| GeneOntologyMolecularFunction | beta-2-microglobulin binding | 1.75e-04 | 12 | 190 | 3 | GO:0030881 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 2.86e-04 | 14 | 190 | 3 | GO:0015386 | |
| GeneOntologyMolecularFunction | 1-phosphatidylinositol binding | 5.23e-04 | 17 | 190 | 3 | GO:0005545 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 7.34e-04 | 19 | 190 | 3 | GO:0022821 | |
| GeneOntologyMolecularFunction | T cell receptor binding | 8.58e-04 | 20 | 190 | 3 | GO:0042608 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 8.84e-04 | 5 | 190 | 2 | GO:0047006 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CFH HLA-A CDHR2 RC3H1 NCAM2 ITGA2 ADGRV1 ITGA4 ITGA7 ITGB4 TENM2 DSCAML1 TYRO3 PTPN6 FAT1 NRXN2 PTPRM VNN1 ZC3H12D DLG2 COL14A1 SDK1 FAT4 DSG1 FAT3 IGDCC4 TENM4 TENM3 TLN1 ASS1 KIRREL1 CDH18 | 2.76e-09 | 1077 | 187 | 32 | GO:0098609 |
| GeneOntologyBiologicalProcess | sensory organ development | CFH CPAMD8 HLA-A HLA-C RHOJ HLA-H TCIRG1 ADGRV1 RRM1 MKS1 HOXA2 FAT1 PXDN PTPRM KCNK3 SDK1 SLC17A6 FAT4 XRN2 FAT3 TENM3 | 3.15e-06 | 730 | 187 | 21 | GO:0007423 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | CDHR2 ITGA4 TENM2 DSCAML1 FAT1 PTPRM SDK1 FAT4 DSG1 FAT3 TENM4 TENM3 CDH18 | 5.97e-06 | 313 | 187 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 8.32e-06 | 187 | 187 | 10 | GO:0007156 | |
| GeneOntologyBiologicalProcess | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent | 3.97e-05 | 8 | 187 | 3 | GO:0002485 | |
| GeneOntologyCellularComponent | anchoring junction | CDHR2 OBSCN ITGA2 ITGA4 ITGA7 EPB41L3 ITGB4 TENM2 B4GALT1 FAP PTPN6 FAT1 PTPRM DLG2 PLCG1 NRAP DSG1 TGM2 IGF2R TLN1 KIRREL1 PEAK1 SCIN CDH18 ATP6V0A2 | 2.40e-06 | 976 | 188 | 25 | GO:0070161 |
| GeneOntologyCellularComponent | zymogen granule | 9.22e-06 | 32 | 188 | 5 | GO:0042588 | |
| GeneOntologyCellularComponent | MHC class Ib protein complex | 2.44e-05 | 7 | 188 | 3 | GO:0032398 | |
| GeneOntologyCellularComponent | secretory granule membrane | HLA-C HLA-H TCIRG1 B4GALT1 ITPR1 TYROBP VNN1 PNLIPRP2 DSG1 ANXA4 SLC9A4 IGF2R | 4.54e-05 | 329 | 188 | 12 | GO:0030667 |
| GeneOntologyCellularComponent | MHC class I protein complex | 8.20e-05 | 10 | 188 | 3 | GO:0042612 | |
| GeneOntologyCellularComponent | vacuolar proton-transporting V-type ATPase, V0 domain | 8.20e-05 | 10 | 188 | 3 | GO:0000220 | |
| GeneOntologyCellularComponent | phagocytic vesicle membrane | 1.04e-04 | 83 | 188 | 6 | GO:0030670 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.33e-04 | 212 | 188 | 9 | GO:0030666 | |
| GeneOntologyCellularComponent | proton-transporting V-type ATPase, V0 domain | 1.48e-04 | 12 | 188 | 3 | GO:0033179 | |
| GeneOntologyCellularComponent | integrin complex | 1.87e-04 | 32 | 188 | 4 | GO:0008305 | |
| GeneOntologyCellularComponent | MHC class I peptide loading complex | 2.42e-04 | 14 | 188 | 3 | GO:0042824 | |
| GeneOntologyCellularComponent | lumenal side of endoplasmic reticulum membrane | 2.67e-04 | 35 | 188 | 4 | GO:0098553 | |
| GeneOntologyCellularComponent | cell-cell junction | OBSCN ITGA4 EPB41L3 TENM2 B4GALT1 PTPN6 FAT1 PTPRM DLG2 PLCG1 NRAP DSG1 TLN1 KIRREL1 CDH18 | 3.07e-04 | 591 | 188 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | cell surface | CFH HLA-A HLA-C HLA-H ITGA2 ADGRV1 ITGA4 ITGA7 ITGB4 DSCAML1 B4GALT1 TYRO3 TYROBP FAP PXDN KCNJ6 ENOX2 ANXA4 LCT IGF2R TLN1 AOC3 | 4.34e-04 | 1111 | 188 | 22 | GO:0009986 |
| GeneOntologyCellularComponent | cis-Golgi network membrane | 4.44e-04 | 17 | 188 | 3 | GO:0033106 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 5.43e-04 | 42 | 188 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | phagocytic vesicle | 5.58e-04 | 157 | 188 | 7 | GO:0045335 | |
| GeneOntologyCellularComponent | basal part of cell | VSIG1 ITGA2 ITGB4 B4GALT1 FAP NOD1 DLG2 SLC27A5 SLC9A4 ATP6V0A4 ALPK2 | 6.52e-04 | 378 | 188 | 11 | GO:0045178 |
| GeneOntologyCellularComponent | cell-substrate junction | ITGA2 ITGA4 ITGA7 ITGB4 FAP FAT1 NRAP TGM2 IGF2R TLN1 PEAK1 ATP6V0A2 | 7.02e-04 | 443 | 188 | 12 | GO:0030055 |
| GeneOntologyCellularComponent | zymogen granule membrane | 7.29e-04 | 20 | 188 | 3 | GO:0042589 | |
| GeneOntologyCellularComponent | secretory granule | CEL HLA-C HLA-H TCIRG1 F5 B4GALT1 ITPR1 TYROBP PCYOX1L PTPN6 VNN1 OGT PNLIPRP2 DSG1 ANXA4 IDH1 SLC9A4 IGF2R GOLGA7 ATP6V0A2 | 8.37e-04 | 1014 | 188 | 20 | GO:0030141 |
| GeneOntologyCellularComponent | secretory vesicle | CEL HLA-C HLA-H TCIRG1 F5 B4GALT1 ITPR1 TYROBP PCYOX1L PTPN6 VNN1 DLG2 SLC17A6 OGT PNLIPRP2 DSG1 ANXA4 IDH1 SLC9A4 IGF2R GOLGA7 ATP6V0A4 ATP6V0A2 | 8.41e-04 | 1246 | 188 | 23 | GO:0099503 |
| GeneOntologyCellularComponent | lumenal side of membrane | 9.05e-04 | 48 | 188 | 4 | GO:0098576 | |
| GeneOntologyCellularComponent | membrane protein complex | HLA-A HLA-C RPN1 HLA-H TCIRG1 ITGA2 ITGA4 ITGA7 ITGB4 NDUFV1 MEP1B TOMM70 PTPN6 KCNJ6 DLG2 SLC17A6 SESTD1 SUN1 GABBR2 CACNA2D4 IGF2R ATP6V0A4 CATSPERB EPB42 CDH18 ATP6V0A2 | 9.45e-04 | 1498 | 188 | 26 | GO:0098796 |
| GeneOntologyCellularComponent | apical part of cell | CDHR2 USP9X TCIRG1 FAP FAT1 NOD1 NOS3 FAT4 SLC5A10 DSG1 ANXA4 LCT SLC9A4 ATP6V0A4 | 9.69e-04 | 592 | 188 | 14 | GO:0045177 |
| GeneOntologyCellularComponent | Golgi medial cisterna | 1.11e-03 | 23 | 188 | 3 | GO:0005797 | |
| GeneOntologyCellularComponent | muscle tendon junction | 1.18e-03 | 6 | 188 | 2 | GO:0005927 | |
| GeneOntologyCellularComponent | vacuolar proton-transporting V-type ATPase complex | 1.60e-03 | 26 | 188 | 3 | GO:0016471 | |
| GeneOntologyCellularComponent | MHC protein complex | 1.60e-03 | 26 | 188 | 3 | GO:0042611 | |
| GeneOntologyCellularComponent | proton-transporting two-sector ATPase complex, proton-transporting domain | 1.60e-03 | 26 | 188 | 3 | GO:0033177 | |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.96e-03 | 59 | 188 | 4 | GO:0098636 | |
| GeneOntologyCellularComponent | proton-transporting V-type ATPase complex | 2.20e-03 | 29 | 188 | 3 | GO:0033176 | |
| GeneOntologyCellularComponent | Z disc | 2.48e-03 | 151 | 188 | 6 | GO:0030018 | |
| GeneOntologyCellularComponent | endocytic vesicle | HLA-A HLA-C HLA-H TCIRG1 NOD1 NOS3 APOB IGF2R ATP6V0A4 ATP6V0A2 | 2.58e-03 | 384 | 188 | 10 | GO:0030139 |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 3.14e-03 | 212 | 188 | 7 | GO:0031461 | |
| GeneOntologyCellularComponent | actin-based cell projection | 3.77e-03 | 278 | 188 | 8 | GO:0098858 | |
| GeneOntologyCellularComponent | I band | 3.96e-03 | 166 | 188 | 6 | GO:0031674 | |
| Domain | Ig_I-set | IGFN1 PDGFRL OBSCN NCAM2 DSCAML1 TYRO3 PXDN SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 6.50e-07 | 190 | 192 | 12 | IPR013098 |
| Domain | I-set | IGFN1 PDGFRL OBSCN NCAM2 DSCAML1 TYRO3 PXDN SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 6.50e-07 | 190 | 192 | 12 | PF07679 |
| Domain | IGc2 | IGFN1 PDGFRL OBSCN VSIG1 NCAM2 DSCAML1 TYRO3 PXDN SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 9.95e-07 | 235 | 192 | 13 | SM00408 |
| Domain | Ig_sub2 | IGFN1 PDGFRL OBSCN VSIG1 NCAM2 DSCAML1 TYRO3 PXDN SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 9.95e-07 | 235 | 192 | 13 | IPR003598 |
| Domain | Ig-like_fold | IGFN1 HLA-A HLA-C PDGFRL OBSCN HLA-H HAPLN2 VSIG1 NCAM2 ITGB4 DSCAML1 TYRO3 PXDN PTPRM COL14A1 SDK1 PKHD1L1 IGDCC4 TGM2 LINGO1 KIRREL1 ALPK2 EPB42 | 1.05e-06 | 706 | 192 | 23 | IPR013783 |
| Domain | Rhs_assc_core | 1.07e-06 | 3 | 192 | 3 | IPR022385 | |
| Domain | - | IGFN1 HLA-A HLA-C PDGFRL OBSCN HAPLN2 VSIG1 NCAM2 ITGB4 DSCAML1 TYRO3 PXDN PTPRM COL14A1 SDK1 PKHD1L1 IGDCC4 TGM2 LINGO1 KIRREL1 ALPK2 EPB42 | 1.36e-06 | 663 | 192 | 22 | 2.60.40.10 |
| Domain | IG_LIKE | IGFN1 HLA-A HLA-C PDGFRL OBSCN HLA-H HAPLN2 VSIG1 NCAM2 DSCAML1 TYRO3 PXDN PTPRM SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 3.36e-06 | 491 | 192 | 18 | PS50835 |
| Domain | Tox-GHH_dom | 4.25e-06 | 4 | 192 | 3 | IPR028916 | |
| Domain | V_ATPase_I | 4.25e-06 | 4 | 192 | 3 | PF01496 | |
| Domain | Tox-GHH | 4.25e-06 | 4 | 192 | 3 | PF15636 | |
| Domain | Ten_N | 4.25e-06 | 4 | 192 | 3 | IPR009471 | |
| Domain | Ten_N | 4.25e-06 | 4 | 192 | 3 | PF06484 | |
| Domain | TENEURIN_N | 4.25e-06 | 4 | 192 | 3 | PS51361 | |
| Domain | V-type_ATPase_116kDa_su_euka | 4.25e-06 | 4 | 192 | 3 | IPR026028 | |
| Domain | V-ATPase_116kDa_su | 4.25e-06 | 4 | 192 | 3 | IPR002490 | |
| Domain | Ig-like_dom | IGFN1 HLA-A HLA-C PDGFRL OBSCN HLA-H HAPLN2 VSIG1 NCAM2 DSCAML1 TYRO3 PXDN PTPRM SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 4.69e-06 | 503 | 192 | 18 | IPR007110 |
| Domain | fn3 | IGFN1 OBSCN NCAM2 ITGB4 DSCAML1 TYRO3 PTPRM COL14A1 SDK1 IGDCC4 | 6.97e-06 | 162 | 192 | 10 | PF00041 |
| Domain | YD | 1.05e-05 | 5 | 192 | 3 | IPR006530 | |
| Domain | MHC_I_a_C | 2.09e-05 | 6 | 192 | 3 | IPR010579 | |
| Domain | MHC_I_C | 2.09e-05 | 6 | 192 | 3 | PF06623 | |
| Domain | FN3 | IGFN1 OBSCN NCAM2 ITGB4 DSCAML1 TYRO3 PTPRM COL14A1 SDK1 IGDCC4 | 2.22e-05 | 185 | 192 | 10 | SM00060 |
| Domain | IG | IGFN1 PDGFRL OBSCN HAPLN2 VSIG1 NCAM2 DSCAML1 TYRO3 PXDN PTPRM SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 3.15e-05 | 421 | 192 | 15 | SM00409 |
| Domain | Ig_sub | IGFN1 PDGFRL OBSCN HAPLN2 VSIG1 NCAM2 DSCAML1 TYRO3 PXDN PTPRM SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 3.15e-05 | 421 | 192 | 15 | IPR003599 |
| Domain | FN3 | IGFN1 OBSCN NCAM2 ITGB4 DSCAML1 TYRO3 PTPRM COL14A1 SDK1 IGDCC4 | 4.15e-05 | 199 | 192 | 10 | PS50853 |
| Domain | FN3_dom | IGFN1 OBSCN NCAM2 ITGB4 DSCAML1 TYRO3 PTPRM COL14A1 SDK1 IGDCC4 | 6.27e-05 | 209 | 192 | 10 | IPR003961 |
| Domain | ConA-like_dom | 9.25e-05 | 219 | 192 | 10 | IPR013320 | |
| Domain | FERM_CS | 9.79e-05 | 24 | 192 | 4 | IPR019747 | |
| Domain | Transglutaminase_C | 1.22e-04 | 10 | 192 | 3 | IPR008958 | |
| Domain | TPR_2 | 1.59e-04 | 50 | 192 | 5 | PF07719 | |
| Domain | TPR_2 | 1.59e-04 | 50 | 192 | 5 | IPR013105 | |
| Domain | NHL | 2.84e-04 | 13 | 192 | 3 | PS51125 | |
| Domain | Laminin_G | 3.21e-04 | 58 | 192 | 5 | IPR001791 | |
| Domain | FERM_N | 3.51e-04 | 33 | 192 | 4 | IPR018979 | |
| Domain | FERM_N | 3.51e-04 | 33 | 192 | 4 | PF09379 | |
| Domain | - | 4.44e-04 | 95 | 192 | 6 | 2.60.120.200 | |
| Domain | Integrin_alpha_C_CS | 5.43e-04 | 16 | 192 | 3 | IPR018184 | |
| Domain | LAM_G_DOMAIN | 6.08e-04 | 38 | 192 | 4 | PS50025 | |
| Domain | CarboxyPept-like_regulatory | 6.54e-04 | 17 | 192 | 3 | IPR008969 | |
| Domain | TPR-like_helical_dom | 7.04e-04 | 233 | 192 | 9 | IPR011990 | |
| Domain | Laminin_G_2 | 7.41e-04 | 40 | 192 | 4 | PF02210 | |
| Domain | Integrin_alpha-2 | 7.79e-04 | 18 | 192 | 3 | IPR013649 | |
| Domain | INTEGRIN_ALPHA | 7.79e-04 | 18 | 192 | 3 | PS00242 | |
| Domain | Integrin_alpha2 | 7.79e-04 | 18 | 192 | 3 | PF08441 | |
| Domain | Integrin_alpha | 7.79e-04 | 18 | 192 | 3 | IPR000413 | |
| Domain | Int_alpha | 9.18e-04 | 19 | 192 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 9.18e-04 | 19 | 192 | 3 | IPR013519 | |
| Domain | Cadherin_CS | 9.20e-04 | 109 | 192 | 6 | IPR020894 | |
| Domain | IGv | 1.05e-03 | 75 | 192 | 5 | SM00406 | |
| Domain | LamG | 1.07e-03 | 44 | 192 | 4 | SM00282 | |
| Domain | CADHERIN_1 | 1.11e-03 | 113 | 192 | 6 | PS00232 | |
| Domain | Cadherin | 1.11e-03 | 113 | 192 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 1.16e-03 | 114 | 192 | 6 | PS50268 | |
| Domain | - | 1.16e-03 | 114 | 192 | 6 | 2.60.40.60 | |
| Domain | CA | 1.22e-03 | 115 | 192 | 6 | SM00112 | |
| Domain | Ez/rad/moesin-like | 1.24e-03 | 21 | 192 | 3 | IPR000798 | |
| Domain | MHC_I | 1.24e-03 | 21 | 192 | 3 | PF00129 | |
| Domain | MHC_I_a_a1/a2 | 1.24e-03 | 21 | 192 | 3 | IPR001039 | |
| Domain | FERM_M | 1.26e-03 | 46 | 192 | 4 | PF00373 | |
| Domain | Cadherin-like | 1.27e-03 | 116 | 192 | 6 | IPR015919 | |
| Domain | EGF_1 | 1.33e-03 | 255 | 192 | 9 | PS00022 | |
| Domain | Cadherin | 1.39e-03 | 118 | 192 | 6 | IPR002126 | |
| Domain | FG_GAP | 1.43e-03 | 22 | 192 | 3 | PS51470 | |
| Domain | Cupredoxin | 1.43e-03 | 22 | 192 | 3 | IPR008972 | |
| Domain | EGF-like_CS | 1.56e-03 | 261 | 192 | 9 | IPR013032 | |
| Domain | - | 1.60e-03 | 49 | 192 | 4 | 1.20.80.10 | |
| Domain | FERM_central | 1.60e-03 | 49 | 192 | 4 | IPR019748 | |
| Domain | FERM_domain | 1.60e-03 | 49 | 192 | 4 | IPR000299 | |
| Domain | TPR_REGION | 1.61e-03 | 165 | 192 | 7 | PS50293 | |
| Domain | TPR | 1.61e-03 | 165 | 192 | 7 | PS50005 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 1.72e-03 | 50 | 192 | 4 | IPR014352 | |
| Domain | FERM_1 | 1.72e-03 | 50 | 192 | 4 | PS00660 | |
| Domain | FERM_2 | 1.72e-03 | 50 | 192 | 4 | PS00661 | |
| Domain | FERM_3 | 1.72e-03 | 50 | 192 | 4 | PS50057 | |
| Domain | Band_41_domain | 1.72e-03 | 50 | 192 | 4 | IPR019749 | |
| Domain | B41 | 1.72e-03 | 50 | 192 | 4 | SM00295 | |
| Domain | EGF_2 | 1.73e-03 | 265 | 192 | 9 | PS01186 | |
| Domain | FG-GAP | 1.85e-03 | 24 | 192 | 3 | PF01839 | |
| Domain | FG-GAP | 1.85e-03 | 24 | 192 | 3 | IPR013517 | |
| Domain | Integrin_dom | 2.08e-03 | 25 | 192 | 3 | IPR032695 | |
| Domain | TPR_11 | 2.13e-03 | 7 | 192 | 2 | PF13414 | |
| Domain | Glycoside_hydrolase_SF | 2.14e-03 | 53 | 192 | 4 | IPR017853 | |
| Domain | FERM_C | 2.34e-03 | 26 | 192 | 3 | PF09380 | |
| Domain | FERM_PH-like_C | 2.61e-03 | 27 | 192 | 3 | IPR018980 | |
| Domain | FERM_C | 2.61e-03 | 27 | 192 | 3 | SM01196 | |
| Domain | Calx_beta | 2.83e-03 | 8 | 192 | 2 | SM00237 | |
| Domain | Galactose-bd-like | 2.86e-03 | 94 | 192 | 5 | IPR008979 | |
| Domain | EGF | 3.04e-03 | 235 | 192 | 8 | SM00181 | |
| Domain | EGF_3 | 3.04e-03 | 235 | 192 | 8 | PS50026 | |
| Domain | PTPc_motif | 3.17e-03 | 59 | 192 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.17e-03 | 59 | 192 | 4 | IPR003595 | |
| Domain | Transglut_N | 3.61e-03 | 9 | 192 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 3.61e-03 | 9 | 192 | 2 | PS00547 | |
| Domain | Calx_beta | 3.61e-03 | 9 | 192 | 2 | IPR003644 | |
| Domain | - | 3.61e-03 | 9 | 192 | 2 | 3.90.260.10 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 3.61e-03 | 9 | 192 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 3.61e-03 | 9 | 192 | 2 | IPR013808 | |
| Domain | Transglutaminase_N | 3.61e-03 | 9 | 192 | 2 | IPR001102 | |
| Domain | Transglut_C | 3.61e-03 | 9 | 192 | 2 | PF00927 | |
| Domain | Calx-beta | 3.61e-03 | 9 | 192 | 2 | PF03160 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY | 1.12e-05 | 30 | 142 | 5 | M47724 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY | 7.53e-05 | 23 | 142 | 4 | M47720 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 7.53e-05 | 23 | 142 | 4 | M47537 | |
| Pathway | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | 8.04e-05 | 9 | 142 | 3 | MM14527 | |
| Pathway | BIOCARTA_NKCELLS_PATHWAY | 1.06e-04 | 25 | 142 | 4 | MM1465 | |
| Pathway | PID_INTEGRIN_CS_PATHWAY | 1.24e-04 | 26 | 142 | 4 | M47 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 1.24e-04 | 26 | 142 | 4 | M47719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY | 1.67e-04 | 28 | 142 | 4 | M47655 | |
| Pathway | REACTOME_DAP12_INTERACTIONS | 2.06e-04 | 54 | 142 | 5 | MM14871 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 2.21e-04 | 30 | 142 | 4 | M47718 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 2.92e-04 | 90 | 142 | 6 | M835 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | CFH HLA-A HLA-C RPN1 ITGA2 SSR2 ITGA7 RRM1 ITGB4 B4GALT1 ITPR1 PCYOX1L FAP FAT1 PXDN CPSF1 TMCO3 FAT4 RBM4 SUN1 RNF149 MANEA TGM2 IGF2R TENM3 KIRREL1 PCOLCE2 ALG3 ATP6V0A2 | 3.02e-11 | 1201 | 193 | 29 | 35696571 |
| Pubmed | TTC14 OBSCN AKR1C4 KLHL32 ITGB4 LCMT2 ITPR1 ZNF780A CRYBG1 PLCG1 USF2 SESTD1 OGT UBE2Q1 SUN1 XIAP APOB FEM1B IGF2R INF2 DNAAF10 PEAK1 ATP6V0A2 | 4.30e-08 | 1084 | 193 | 23 | 11544199 | |
| Pubmed | 2.94e-07 | 11 | 193 | 4 | 15128777 | ||
| Pubmed | Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate. | 2.94e-07 | 11 | 193 | 4 | 29988124 | |
| Pubmed | 3.37e-07 | 162 | 193 | 9 | 25826454 | ||
| Pubmed | Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus. | 4.39e-07 | 12 | 193 | 4 | 25902529 | |
| Pubmed | AGO2 HLA-A HLA-C USP9X PPP1R12B ITPR1 TOMM70 PTPN3 PTPN6 ZFYVE9 PTPRM CPSF1 RELCH SUN1 MTMR8 NBEA IGF2R DNAAF10 KIRREL1 PEAK1 SCIN | 4.47e-07 | 1049 | 193 | 21 | 27880917 | |
| Pubmed | All four members of the Ten-m/Odz family of transmembrane proteins form dimers. | 6.70e-07 | 4 | 193 | 3 | 12000766 | |
| Pubmed | Mouse ten-m/Odz is a new family of dimeric type II transmembrane proteins expressed in many tissues. | 6.70e-07 | 4 | 193 | 3 | 10225957 | |
| Pubmed | 6.70e-07 | 4 | 193 | 3 | 17595521 | ||
| Pubmed | 1.67e-06 | 5 | 193 | 3 | 35948619 | ||
| Pubmed | 2.65e-06 | 18 | 193 | 4 | 4353891 | ||
| Pubmed | Aldolase directly interacts with ARNO and modulates cell morphology and acidic vesicle distribution. | 3.32e-06 | 6 | 193 | 3 | 21307348 | |
| Pubmed | 3.66e-06 | 74 | 193 | 6 | 15031102 | ||
| Pubmed | 4.06e-06 | 164 | 193 | 8 | 32409323 | ||
| Pubmed | 4.15e-06 | 20 | 193 | 4 | 22687584 | ||
| Pubmed | HLA-A HLA-C ITGA2 ITGA4 ITGA7 ZFYVE9 PTPRM IGF2R TENM3 INF2 KIRREL1 PEAK1 | 4.65e-06 | 421 | 193 | 12 | 36976175 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 5.31e-06 | 226 | 193 | 9 | 37839992 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 2808323 | ||
| Pubmed | Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense. | 5.79e-06 | 7 | 193 | 3 | 12459592 | |
| Pubmed | A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity. | 5.79e-06 | 7 | 193 | 3 | 28234229 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 2642506 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 9037062 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 20957233 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 11580250 | ||
| Pubmed | Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire. | 5.79e-06 | 7 | 193 | 3 | 20974936 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10704462 | ||
| Pubmed | A novel H-2K splice form: predictions for other alternative H-2 splicing events. | 5.79e-06 | 7 | 193 | 3 | 2908875 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 3458188 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 19462379 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 6300887 | ||
| Pubmed | H-2-linked regulation of xenotropic murine leukemia virus expression. | 5.79e-06 | 7 | 193 | 3 | 6300850 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 8500526 | ||
| Pubmed | cDNA clone coding for part of a mouse H-2d major histocompatibility antigen. | 5.79e-06 | 7 | 193 | 3 | 6265910 | |
| Pubmed | DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17. | 5.79e-06 | 7 | 193 | 3 | 2906539 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 3013627 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 3894562 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 1348042 | ||
| Pubmed | H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning. | 5.79e-06 | 7 | 193 | 3 | 19346486 | |
| Pubmed | Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. | 5.79e-06 | 7 | 193 | 3 | 18383043 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 8833240 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 21178009 | ||
| Pubmed | Extensive deletions in the Q region of the mouse major histocompatibility complex. | 5.79e-06 | 7 | 193 | 3 | 3025084 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 16059920 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 2989712 | ||
| Pubmed | Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1. | 5.79e-06 | 7 | 193 | 3 | 1280760 | |
| Pubmed | Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes. | 5.79e-06 | 7 | 193 | 3 | 6786753 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 6583704 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 6571712 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 12006653 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 7520098 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10452993 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 26714929 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 6280871 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10799615 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10993729 | ||
| Pubmed | MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus. | 5.79e-06 | 7 | 193 | 3 | 19454713 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10229092 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 2879284 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 7306483 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 2351932 | ||
| Pubmed | Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation. | 5.79e-06 | 7 | 193 | 3 | 1731192 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 1627536 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 32341060 | ||
| Pubmed | H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice. | 5.79e-06 | 7 | 193 | 3 | 2422118 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 34181639 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 20711468 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 15809355 | ||
| Pubmed | Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains. | 5.79e-06 | 7 | 193 | 3 | 3840195 | |
| Pubmed | Mouse histocompatibility genes: structure and organisation of a Kd gene. | 5.79e-06 | 7 | 193 | 3 | 11894934 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 19700752 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 11894963 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 22287714 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 2997361 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 9869916 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 312902 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 3335396 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 6689056 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 16461341 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 6895187 | ||
| Pubmed | Genetic control of corticosteroid side-chain isomerase activity in the mouse. | 5.79e-06 | 7 | 193 | 3 | 6822218 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 15210799 | ||
| Pubmed | NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection. | 5.79e-06 | 7 | 193 | 3 | 19820922 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 8181071 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 23142461 | ||
| Pubmed | Structure of C-terminal half of two H-2 antigens from cloned mRNA. | 5.79e-06 | 7 | 193 | 3 | 6895103 | |
| Pubmed | Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice. | 5.79e-06 | 7 | 193 | 3 | 7759137 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 6799575 | ||
| Pubmed | Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice. | 5.79e-06 | 7 | 193 | 3 | 6966299 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 12140378 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 2410925 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 12421934 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 3840763 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 12421940 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 9770513 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 19195028 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 16473882 | ||
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 10479061 | ||
| Pubmed | Structural relationships among the H-2 D-regions of murine MHC haplotypes. | 5.79e-06 | 7 | 193 | 3 | 2909618 | |
| Pubmed | 5.79e-06 | 7 | 193 | 3 | 8168857 | ||
| Interaction | LILRB1 interactions | 1.57e-06 | 10 | 191 | 4 | int:LILRB1 | |
| Interaction | UCN3 interactions | 2.13e-06 | 23 | 191 | 5 | int:UCN3 | |
| Interaction | PSG8 interactions | 2.29e-06 | 41 | 191 | 6 | int:PSG8 | |
| Interaction | ATP6V0A4 interactions | 5.97e-06 | 28 | 191 | 5 | int:ATP6V0A4 | |
| Interaction | PSG1 interactions | 8.46e-06 | 51 | 191 | 6 | int:PSG1 | |
| Interaction | LLCFC1 interactions | 2.03e-05 | 121 | 191 | 8 | int:LLCFC1 | |
| Interaction | RHOA interactions | HLA-A HLA-C RHOJ RPN1 USP9X ITGA2 EPB41L3 TRRAP TENM2 NDUFV1 ITPR1 FAT1 ZFYVE9 PLCG1 VPS51 SDK1 SMURF2 FAT4 SUN1 RNF149 TGM2 IGF2R TENM3 INF2 KIRREL1 PEAK1 ATP6V0A2 | 2.54e-05 | 1199 | 191 | 27 | int:RHOA |
| Interaction | LCN6 interactions | 4.14e-05 | 67 | 191 | 6 | int:LCN6 | |
| Interaction | ANPEP interactions | 4.35e-05 | 174 | 191 | 9 | int:ANPEP | |
| Interaction | CCL3 interactions | 5.20e-05 | 178 | 191 | 9 | int:CCL3 | |
| Interaction | LOC254896 interactions | 5.21e-05 | 43 | 191 | 5 | int:LOC254896 | |
| Interaction | C2CD4B interactions | 5.84e-05 | 44 | 191 | 5 | int:C2CD4B | |
| Interaction | SCGB2A1 interactions | 6.02e-05 | 104 | 191 | 7 | int:SCGB2A1 | |
| Interaction | LGALS1 interactions | CDHR2 ITGA2 ITGA4 ITGA7 SDK1 FAT4 FAT3 IGDCC4 IGF2R TENM3 SMN1 ATP6V0A2 | 8.16e-05 | 332 | 191 | 12 | int:LGALS1 |
| Interaction | CD160 interactions | 8.93e-05 | 48 | 191 | 5 | int:CD160 | |
| Interaction | DKKL1 interactions | 9.11e-05 | 111 | 191 | 7 | int:DKKL1 | |
| Interaction | LILRB2 interactions | 9.58e-05 | 10 | 191 | 3 | int:LILRB2 | |
| Cytoband | 11q13 | 1.14e-05 | 118 | 193 | 6 | 11q13 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | IGFN1 PDGFRL OBSCN NCAM2 DSCAML1 TYRO3 PXDN PTPRM SDK1 IGDCC4 LINGO1 KIRREL1 ALPK2 | 3.07e-10 | 161 | 138 | 13 | 593 |
| GeneFamily | Fibronectin type III domain containing | IGFN1 OBSCN NCAM2 ITGB4 DSCAML1 TYRO3 PTPRM COL14A1 SDK1 IGDCC4 | 4.16e-07 | 160 | 138 | 10 | 555 |
| GeneFamily | Cadherin related | 7.16e-06 | 17 | 138 | 4 | 24 | |
| GeneFamily | Immunoglobulin like domain containing | 1.19e-04 | 193 | 138 | 8 | 594 | |
| GeneFamily | CD molecules|Integrin alpha subunits | 3.26e-04 | 18 | 138 | 3 | 1160 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 5.70e-04 | 50 | 138 | 4 | 1293 | |
| GeneFamily | V-type ATPases | 6.89e-04 | 23 | 138 | 3 | 415 | |
| GeneFamily | Transglutaminases | 2.01e-03 | 9 | 138 | 2 | 773 | |
| GeneFamily | Zinc fingers CCCH-type | 2.38e-03 | 35 | 138 | 3 | 73 | |
| GeneFamily | Cyclins|F-boxes other | 3.25e-03 | 39 | 138 | 3 | 560 | |
| GeneFamily | Histocompatibility complex|C1-set domain containing | 4.58e-03 | 44 | 138 | 3 | 588 | |
| Coexpression | GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS | 1.74e-07 | 115 | 191 | 9 | M43621 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | CFH PDGFRL RHOJ NCAM2 TENM2 FAP FAT1 NRXN2 PTPRM COL14A1 TRHDE OLFML2B FAT3 APOB IGDCC4 TENM4 LINGO1 ASS1 KIRREL1 SMAD9 | 9.32e-07 | 767 | 191 | 20 | M39209 |
| Coexpression | CASTELLANO_NRAS_TARGETS_UP | 3.77e-06 | 88 | 191 | 7 | MM1087 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | CFH HLA-A HLA-C TTC14 HLA-H CUL9 TRRAP ADCY1 LCMT2 ITPR1 TYRO3 ZFYVE9 NRXN2 KCNJ6 KLHL23 XRN2 GPT RNF149 KCTD17 FEM1B INF2 | 6.99e-06 | 954 | 191 | 21 | MM3689 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL | CFH PDGFRL USP9X NCAM2 TENM2 TYRO3 NRXN2 OCIAD2 DLG2 TMCO3 MN1 UBE2Q1 OLFML2B PKHD1L1 DOK4 INF2 ASS1 TM7SF2 KIRREL1 PCOLCE2 EPB42 | 7.10e-06 | 955 | 191 | 21 | M45680 |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING | 1.21e-05 | 20 | 191 | 4 | MM3682 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP | 1.71e-05 | 200 | 191 | 9 | M7471 | |
| Coexpression | GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN | 1.71e-05 | 200 | 191 | 9 | M6396 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CFH CPAMD8 RHOJ OBSCN ITGA7 CSMD3 ITPR1 PXDN PTPRM COL14A1 IGDCC4 TGM2 AOC3 KIRREL1 | 2.20e-05 | 505 | 191 | 14 | M39167 |
| Coexpression | ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN | ADAD1 TDRD9 CDHR2 PPP1R12B OBSCN ADGRV1 CSMD3 TENM2 PTPN3 PXDN ASB5 SDK1 NRAP PNLIPRP2 OLFML2B FHOD3 KIRREL1 SCIN SMAD9 | 2.29e-05 | 873 | 191 | 19 | M16009 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | CSMD3 KLHL32 ADCY1 PTPN3 NRXN2 KCNJ6 SLC17A6 TRHDE FAT4 FAT3 NBEA GABBR2 IGDCC4 LINGO1 DOK4 | 2.70e-05 | 584 | 191 | 15 | M39068 |
| Coexpression | TABULA_MURIS_SENIS_LIMB_MUSCLE_SMOOTH_MUSCLE_CELL_AGEING | 5.87e-05 | 92 | 191 | 6 | MM3748 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING | 7.09e-05 | 59 | 191 | 5 | MM3688 | |
| Coexpression | HEVNER_CORTEX_CAUDAL_CORTICAL_PLATE | 7.37e-05 | 31 | 191 | 4 | MM439 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | TBC1D9B SAMD9 NAB2 CUL9 AKR1C4 ITGA7 EPB41L4A MKS1 PTPN6 CPSF1 PLCG1 HSD17B2 CTH KCTD2 | 7.66e-05 | 567 | 191 | 14 | M16909 |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | CFH HLA-A HLA-C RC3H1 HLA-H SSR2 ITGA7 B4GALT1 ITPR1 PTPN6 PXDN NME7 MN1 C1orf43 ZC3H18 TLN1 | 8.55e-05 | 723 | 191 | 16 | MM3672 |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN | 1.11e-04 | 199 | 191 | 8 | M5682 | |
| Coexpression | GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 1.15e-04 | 200 | 191 | 8 | M6212 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP | 1.15e-04 | 200 | 191 | 8 | M5046 | |
| Coexpression | SMID_BREAST_CANCER_ERBB2_UP | 1.30e-04 | 152 | 191 | 7 | M3102 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 1.31e-04 | 14 | 191 | 3 | M1943 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 OBSCN NCAM2 ADGRV1 CSMD3 DSCAML1 FAT1 SDK1 TRHDE FAT4 FAT3 APOB PKHD1L1 TENM4 | 8.26e-14 | 184 | 193 | 14 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 OBSCN NCAM2 ADGRV1 CSMD3 DSCAML1 FAT1 SDK1 TRHDE FAT4 FAT3 APOB PKHD1L1 TENM4 | 8.26e-14 | 184 | 193 | 14 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | IGFN1 OBSCN NCAM2 ADGRV1 CSMD3 DSCAML1 FAT1 SDK1 TRHDE FAT4 FAT3 APOB PKHD1L1 TENM4 | 8.26e-14 | 184 | 193 | 14 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 8.47e-10 | 192 | 193 | 11 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | HLA-A HLA-H NDST4 ITGA7 PTPRM SDK1 FAT4 OVOS2 IGDCC4 KIRREL1 | 9.76e-09 | 187 | 193 | 10 | 02105c82a9ba79d2f19e002188377fc3440770c2 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-08 | 194 | 193 | 10 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | PTPN3 FAT1 OLFML2B FAT3 TENM4 LINGO1 TENM3 KIRREL1 PCOLCE2 SCIN | 1.60e-08 | 197 | 193 | 10 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e |
| ToppCell | distal-mesenchymal-Vascular_Smooth_Muscle-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | PPP1R12B HAPLN2 ITGA7 KLHL23 KCNK3 COL14A1 OLFML2B APOB AOC3 RASL11B | 1.60e-08 | 197 | 193 | 10 | da653dc7d216e202f390e5ab0245f243e3ed213b |
| ToppCell | distal-2-mesenchymal-Vascular_Smooth_Muscle|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | PPP1R12B HAPLN2 ITGA7 KLHL23 KCNK3 COL14A1 OLFML2B APOB AOC3 RASL11B | 1.68e-08 | 198 | 193 | 10 | ce05ede69c167b2294630709bb0c223483a6ef75 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-08 | 155 | 193 | 9 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2-Tnr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.29e-08 | 122 | 193 | 8 | cffd7730bda90828efc0def452cabb44cf93ab48 | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE-O2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.29e-08 | 122 | 193 | 8 | 2880f25d10a7765e55a2aa20c7a6ef74cea19c4d | |
| ToppCell | Frontal_cortex-Macroglia-OLIGODENDROCYTE|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.29e-08 | 122 | 193 | 8 | ecd0e54dd829201290212ea2ff7c8e7eec19c0e9 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.80e-08 | 178 | 193 | 9 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-07 | 181 | 193 | 9 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-07 | 183 | 193 | 9 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.34e-07 | 187 | 193 | 9 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.40e-07 | 188 | 193 | 9 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-07 | 188 | 193 | 9 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-07 | 189 | 193 | 9 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-07 | 194 | 193 | 9 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 1.83e-07 | 194 | 193 | 9 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-07 | 196 | 193 | 9 | 545d2e4469924d333e3f655f559c899fa1260196 | |
| ToppCell | ILEUM-inflamed-(8)_Pericytes|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.09e-07 | 197 | 193 | 9 | e04ac8575f66d798ddf2fd6d55d397a163b40732 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-07 | 198 | 193 | 9 | 1f956e369e00d37835095a001db4b62a79014532 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-07 | 198 | 193 | 9 | dc6fbad0ecdd057189f71afcdb6aca25207314a3 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.37e-07 | 200 | 193 | 9 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 200 | 193 | 9 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 200 | 193 | 9 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.94e-07 | 112 | 193 | 7 | cb351e57c99aaaf9ae6c7ff7e8ce5375552b1639 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.94e-07 | 112 | 193 | 7 | 999b5eeed4305e1a1385aadbaf017b64f21c1ee0 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1-Trf-Oligodendrocyte.Trf.Il33_(Il33)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.94e-07 | 112 | 193 | 7 | 004cd69b66c3b26b9a61f03279b48230da351574 | |
| ToppCell | Thalamus-Macroglia-OLIGODENDROCYTE-O1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 5.94e-07 | 112 | 193 | 7 | 502e3f356f6e1c959bff0a39c98f33f863ce8265 | |
| ToppCell | droplet-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.40e-07 | 165 | 193 | 8 | 622aca1d49bd8c917b131e4f4959d9dba411d22b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-07 | 165 | 193 | 8 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.34e-07 | 168 | 193 | 8 | 6a233045638cb83dab64789b996b7598c325001e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.02e-07 | 170 | 193 | 8 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.45e-07 | 118 | 193 | 7 | d0dd5c882cd9e0a5eb0cb08e47877292126bd4ae | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O1-Trf|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.45e-07 | 118 | 193 | 7 | 4283699cb3ca7a112faa07727dfdc0b0a67fb779 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.76e-07 | 172 | 193 | 8 | 6c17a1e586a72d1bd80c20c06370429c61dc9f85 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.98e-07 | 175 | 193 | 8 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.98e-07 | 175 | 193 | 8 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(MyelinProcesses)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.06e-06 | 77 | 193 | 6 | 4720aa099bd00d05b721634eedc9a08b0213ee67 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(MyelinProcesses)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.06e-06 | 77 | 193 | 6 | 25a8dd4cdba4d96d6b0c35fa6310bfff6ce64265 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-06 | 177 | 193 | 8 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 1.09e-06 | 177 | 193 | 8 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-06 | 177 | 193 | 8 | 1cb78133ac09ea3a3f5b5de07151033998406512 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.09e-06 | 177 | 193 | 8 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.18e-06 | 179 | 193 | 8 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.18e-06 | 179 | 193 | 8 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-06 | 180 | 193 | 8 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ionocyte|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-06 | 180 | 193 | 8 | 8af8b4af2dc72223ac71fc027e0d4280c5dd81f8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 181 | 193 | 8 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.34e-06 | 182 | 193 | 8 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 183 | 193 | 8 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.40e-06 | 183 | 193 | 8 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-06 | 183 | 193 | 8 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.40e-06 | 183 | 193 | 8 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.40e-06 | 183 | 193 | 8 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 185 | 193 | 8 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.51e-06 | 185 | 193 | 8 | 1b990e3089772be2b38c6d7ea0d1bf22461ae3ea | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-06 | 185 | 193 | 8 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 185 | 193 | 8 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-06 | 185 | 193 | 8 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.62e-06 | 130 | 193 | 7 | 0a6b87635e650df431a88f2e6396abead84d901d | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.64e-06 | 187 | 193 | 8 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.64e-06 | 187 | 193 | 8 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 1.78e-06 | 189 | 193 | 8 | 9c407b17d7945e81e1ae6c18452f5d20fb09d563 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-06 | 190 | 193 | 8 | ad0d9aed8c9c99551765d14730d70ebef1ea856b | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-06 | 192 | 193 | 8 | c3707243c5590d852c9f28429c96f50a1fa6b0dc | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-06 | 192 | 193 | 8 | f9fb24457999dc9e751a099d7f995543b9330ad4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 192 | 193 | 8 | 0bb06738e1c3ec0c044a7ee61f6cf1d4781fb53c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.00e-06 | 192 | 193 | 8 | 2cc712186e37fb21a964c032765c36a8b4a852cf | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.08e-06 | 193 | 193 | 8 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.08e-06 | 193 | 193 | 8 | 7386fadc13a437f3b0c99b5d116cd3c5f893529c | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-06 | 194 | 193 | 8 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 194 | 193 | 8 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 194 | 193 | 8 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-06 | 194 | 193 | 8 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-06 | 195 | 193 | 8 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 195 | 193 | 8 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.24e-06 | 195 | 193 | 8 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.24e-06 | 195 | 193 | 8 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 195 | 193 | 8 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-06 | 196 | 193 | 8 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.33e-06 | 196 | 193 | 8 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-06 | 197 | 193 | 8 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.42e-06 | 197 | 193 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.42e-06 | 197 | 193 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Striatum-Macroglia-OLIGODENDROCYTE|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.49e-06 | 89 | 193 | 6 | ee1dd3571f5914a8274b71f9ca8b36132ae87fe1 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 198 | 193 | 8 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.51e-06 | 198 | 193 | 8 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 198 | 193 | 8 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 198 | 193 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.51e-06 | 198 | 193 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Enterocyte-C_01|Enterocyte / shred on cell type and cluster | 2.51e-06 | 198 | 193 | 8 | 4e2c30d6fd1d59db98a52bfcc3206b4c4ac5abe2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 199 | 193 | 8 | b9338b739162cd8e5661c9a4dcb41a31219b5723 | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 199 | 193 | 8 | ad75e5e26c37a97331164d7f77235ebd9a933a44 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 199 | 193 | 8 | c972d3036151403f26fa9d6271520639c281ab84 | |
| Drug | kalinin | 4.06e-07 | 55 | 193 | 7 | CID000032518 | |
| Drug | Lndfh-ii | 1.58e-06 | 11 | 193 | 4 | CID000124919 | |
| Drug | N-acetylhexosamine | NCAM2 ITGA2 ITGA4 ITGA7 F5 ITGB4 B4GALT1 FAP PTPRM OGT PNLIPRP2 GPT IGF2R LINGO1 AOC3 SMN1 | 2.94e-06 | 472 | 193 | 16 | CID000000899 |
| Drug | hydroxyl radicals | CEL HLA-A GANC RHOJ USP9X GLB1L TCIRG1 AKR1C4 ITGA2 RRM1 F5 PTPN3 PCYOX1L PTPN6 PTPRM VNN1 PLCG1 NOS3 SLC27A5 PNLIPRP2 IDH1 LCT USP2 ATP6V0A4 AOC3 TM7SF2 CTH ATP6V0A2 | 9.33e-06 | 1341 | 193 | 28 | CID000000961 |
| Disease | uric acid measurement | CEL ADGRV1 EPB41L3 F5 TENM2 B4GALT1 FAP NRXN2 VPS51 SLC27A5 SESTD1 FAT4 FAT3 METTL6 USP2 EFNA3 | 1.69e-06 | 610 | 185 | 16 | EFO_0004761 |
| Disease | autosomal recessive osteopetrosis 1 (implicated_via_orthology) | 2.40e-06 | 5 | 185 | 3 | DOID:0110942 (implicated_via_orthology) | |
| Disease | Astrocytosis | 3.34e-06 | 17 | 185 | 4 | C3887640 | |
| Disease | Gliosis | 3.34e-06 | 17 | 185 | 4 | C0017639 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 1.33e-05 | 8 | 185 | 3 | DOID:14219 (implicated_via_orthology) | |
| Disease | Paranoia | 3.86e-05 | 11 | 185 | 3 | C1456784 | |
| Disease | neutrophil count, eosinophil count | 6.33e-05 | 213 | 185 | 8 | EFO_0004833, EFO_0004842 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 6.62e-05 | 13 | 185 | 3 | EFO_0802114 | |
| Disease | Lymphohistiocytosis, Hemophagocytic | 1.17e-04 | 3 | 185 | 2 | C0024291 | |
| Disease | Retinal Vein Occlusion | 1.17e-04 | 3 | 185 | 2 | C0035328 | |
| Disease | Thrombosis of retinal vein | 1.17e-04 | 3 | 185 | 2 | C1527411 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.82e-04 | 45 | 185 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | triacylglycerol 54:4 measurement | 1.99e-04 | 46 | 185 | 4 | EFO_0010422 | |
| Disease | Heritable pulmonary arterial hypertension | 2.33e-04 | 4 | 185 | 2 | cv:C0340543 | |
| Disease | EH domain-binding protein 1 measurement | 2.33e-04 | 4 | 185 | 2 | EFO_0801561 | |
| Disease | vulva cancer (is_implicated_in) | 2.33e-04 | 4 | 185 | 2 | DOID:1245 (is_implicated_in) | |
| Disease | E3 ubiquitin-protein ligase DTX1 measurement | 2.33e-04 | 4 | 185 | 2 | EFO_0802503 | |
| Disease | uncharacterized protein KIAA0040 measurement | 2.33e-04 | 4 | 185 | 2 | EFO_0802196 | |
| Disease | isochorismatase domain-containing protein 1 measurement | 2.33e-04 | 4 | 185 | 2 | EFO_0801735 | |
| Disease | guanylyl cyclase-activating protein 1 measurement | 2.33e-04 | 4 | 185 | 2 | EFO_0801663 | |
| Disease | Fetal Growth Retardation | 2.56e-04 | 20 | 185 | 3 | C0015934 | |
| Disease | diabetic retinopathy (is_implicated_in) | 2.75e-04 | 50 | 185 | 4 | DOID:8947 (is_implicated_in) | |
| Disease | Idiopathic pulmonary arterial hypertension | 3.86e-04 | 5 | 185 | 2 | cv:C3203102 | |
| Disease | Anterior segment mesenchymal dysgenesis | 3.86e-04 | 5 | 185 | 2 | C1862839 | |
| Disease | monocyte:lymphocyte ratio | 3.86e-04 | 5 | 185 | 2 | EFO_0007956 | |
| Disease | Primary pulmonary hypertension | 3.86e-04 | 5 | 185 | 2 | cv:C0152171 | |
| Disease | Idiopathic and/or familial pulmonary arterial hypertension | 3.86e-04 | 5 | 185 | 2 | cv:C5679820 | |
| Disease | STROKE, ISCHEMIC | 3.86e-04 | 5 | 185 | 2 | 601367 | |
| Disease | Ischemic stroke | 3.86e-04 | 5 | 185 | 2 | cv:C0948008 | |
| Disease | prolyl endopeptidase FAP measurement | 3.86e-04 | 5 | 185 | 2 | EFO_0021856 | |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 4.46e-04 | 216 | 185 | 7 | EFO_0007925, EFO_0007927 | |
| Disease | response to TNF antagonist, joint damage measurement | 5.04e-04 | 25 | 185 | 3 | EFO_0004653, EFO_0005413 | |
| Disease | neutrophil count, basophil count | 5.54e-04 | 224 | 185 | 7 | EFO_0004833, EFO_0005090 | |
| Disease | cytochrome c oxidase subunit 6C measurement | 5.77e-04 | 6 | 185 | 2 | EFO_0801515 | |
| Disease | galectin-7 measurement | 5.77e-04 | 6 | 185 | 2 | EFO_0022034 | |
| Disease | primary pulmonary hypertension (is_implicated_in) | 5.77e-04 | 6 | 185 | 2 | DOID:14557 (is_implicated_in) | |
| Disease | serum IgE measurement | 7.09e-04 | 64 | 185 | 4 | EFO_0004579 | |
| Disease | Pulmonary Hypertension, Primary, 1 | 8.04e-04 | 7 | 185 | 2 | C4552070 | |
| Disease | retinal vein occlusion (is_implicated_in) | 8.04e-04 | 7 | 185 | 2 | DOID:1727 (is_implicated_in) | |
| Disease | vascular cell adhesion protein 1 measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0020846 | |
| Disease | atrial natriuretic factor measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0004789 | |
| Disease | Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia | 8.04e-04 | 7 | 185 | 2 | C3714844 | |
| Disease | PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED | 8.04e-04 | 7 | 185 | 2 | C1969342 | |
| Disease | Pulmonary Hypertension, Primary, Fenfluramine-Associated | 8.04e-04 | 7 | 185 | 2 | C1969343 | |
| Disease | graft-versus-host disease (implicated_via_orthology) | 8.04e-04 | 7 | 185 | 2 | DOID:0081267 (implicated_via_orthology) | |
| Disease | glutathione s-transferase p measurement | 8.04e-04 | 7 | 185 | 2 | EFO_0020410 | |
| Disease | Prescription Drug Abuse | 8.07e-04 | 115 | 185 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 8.07e-04 | 115 | 185 | 5 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 8.07e-04 | 115 | 185 | 5 | C0029231 | |
| Disease | Drug habituation | 8.07e-04 | 115 | 185 | 5 | C0013170 | |
| Disease | Drug abuse | 8.07e-04 | 115 | 185 | 5 | C0013146 | |
| Disease | Drug Use Disorders | 8.07e-04 | 115 | 185 | 5 | C0013222 | |
| Disease | Drug Dependence | 8.07e-04 | 115 | 185 | 5 | C1510472 | |
| Disease | Substance Dependence | 8.07e-04 | 115 | 185 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 8.07e-04 | 115 | 185 | 5 | C0038586 | |
| Disease | Substance abuse problem | 8.39e-04 | 116 | 185 | 5 | C0740858 | |
| Disease | obsolete_red blood cell distribution width | ADAD1 SAMD9 AGO2 CEL ZNF366 RC3H1 RRM1 CRYBG1 USF2 XRN2 OGT SLC27A6 SUN1 MKRN2OS APOB KCTD17 PCOLCE2 GALNT6 CDH18 | 8.50e-04 | 1347 | 185 | 19 | EFO_0005192 |
| Disease | response to angiotensin receptor blocker | 8.69e-04 | 30 | 185 | 3 | EFO_0010735 | |
| Disease | glycoprotein measurement | 9.41e-04 | 119 | 185 | 5 | EFO_0004555 | |
| Disease | ferritin measurement | 9.41e-04 | 119 | 185 | 5 | EFO_0004459 | |
| Disease | putamen volume | 9.58e-04 | 31 | 185 | 3 | EFO_0006932 | |
| Disease | Familial pulmonary arterial hypertension | 1.07e-03 | 8 | 185 | 2 | C1701939 | |
| Disease | E3 ubiquitin-protein ligase RNF13 measurement | 1.07e-03 | 8 | 185 | 2 | EFO_0801556 | |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 1.07e-03 | 8 | 185 | 2 | EFO_0020829 | |
| Disease | Anterior segment dysgenesis | 1.07e-03 | 8 | 185 | 2 | cv:C1862839 | |
| Disease | neutrophil count | CPAMD8 CEL HLA-A HLA-C RPN1 ZNF366 RC3H1 EML6 SSR2 ITGA4 TMCO3 UBE2Q1 OLFML2B LCT AZIN1 ANKRD13A LINGO1 KIRREL1 ATP6V0A2 | 1.15e-03 | 1382 | 185 | 19 | EFO_0004833 |
| Disease | granulocyte count | 1.16e-03 | 254 | 185 | 7 | EFO_0007987 | |
| Disease | Autistic Disorder | 1.35e-03 | 261 | 185 | 7 | C0004352 | |
| Disease | Idiopathic pulmonary hypertension | 1.37e-03 | 9 | 185 | 2 | C0152171 | |
| Disease | t-cell surface glycoprotein CD5 measurement | 1.37e-03 | 9 | 185 | 2 | EFO_0803134 | |
| Disease | Hepatocellular carcinoma | 1.37e-03 | 9 | 185 | 2 | cv:C2239176 | |
| Disease | HEPATOCELLULAR CARCINOMA | 1.37e-03 | 9 | 185 | 2 | 114550 | |
| Disease | endothelin-converting enzyme 1 measurement | 1.37e-03 | 9 | 185 | 2 | EFO_0008121 | |
| Disease | Inflammatory Bowel Diseases | 1.37e-03 | 35 | 185 | 3 | C0021390 | |
| Disease | Mitral valve prolapse | 1.49e-03 | 36 | 185 | 3 | HP_0001634 | |
| Disease | Colorectal Carcinoma | CPAMD8 PDGFRL OBSCN CSMD3 F5 DSCAML1 FAT1 RELCH APOB IDH1 TGM2 SMAD9 | 1.67e-03 | 702 | 185 | 12 | C0009402 |
| Disease | dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 measurement | 1.70e-03 | 10 | 185 | 2 | EFO_0801544 | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 1.70e-03 | 10 | 185 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | Pulmonary arterial hypertension | 1.70e-03 | 10 | 185 | 2 | C2973725 | |
| Disease | obstructive jaundice (biomarker_via_orthology) | 1.70e-03 | 10 | 185 | 2 | DOID:13603 (biomarker_via_orthology) | |
| Disease | progression free survival, response to carboplatin, methylcobalamin deficiency type cblE, ovarian carcinoma | 1.88e-03 | 39 | 185 | 3 | EFO_0001075, EFO_0004920, GO_0097328, MONDO_0009354 | |
| Disease | lobe attachment | 2.01e-03 | 207 | 185 | 6 | EFO_0007667 | |
| Disease | Cerebral Infarction, Left Hemisphere | 2.07e-03 | 11 | 185 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 2.07e-03 | 11 | 185 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 2.07e-03 | 11 | 185 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 2.07e-03 | 11 | 185 | 2 | C0751014 | |
| Disease | Cerebral Infarction | 2.07e-03 | 11 | 185 | 2 | C0007785 | |
| Disease | cytochrome p450 3a4 measurement | 2.07e-03 | 11 | 185 | 2 | EFO_0020303 | |
| Disease | quality of life during menstruation measurement, acne | 2.07e-03 | 11 | 185 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | Posterior Choroidal Artery Infarction | 2.07e-03 | 11 | 185 | 2 | C0887799 | |
| Disease | anti-SARS-CoV-2 IgG measurement, response to COVID-19 vaccine | 2.07e-03 | 11 | 185 | 2 | EFO_0803358, EFO_0803362 | |
| Disease | beta-2 microglobulin measurement | 2.07e-03 | 11 | 185 | 2 | EFO_0005197 | |
| Disease | stroke | 2.19e-03 | 144 | 185 | 5 | EFO_0000712 | |
| Disease | myeloid white cell count | CEL HLA-A HLA-C RPN1 ZNF366 RC3H1 EML6 SSR2 ITGA4 FAP TMCO3 LCT TGM2 KIRREL1 | 2.45e-03 | 937 | 185 | 14 | EFO_0007988 |
| Disease | insomnia, total blood protein measurement | 2.46e-03 | 148 | 185 | 5 | EFO_0004536, EFO_0004698 | |
| Disease | IgG galactosylation measurement | 2.48e-03 | 12 | 185 | 2 | EFO_0008425 | |
| Disease | level of C-X-C motif chemokine 2 in blood serum | 2.48e-03 | 12 | 185 | 2 | OBA_2041207 | |
| Disease | hip geometry | 2.66e-03 | 44 | 185 | 3 | EFO_0004685 | |
| Disease | periodontitis | 2.91e-03 | 223 | 185 | 6 | EFO_0000649 | |
| Disease | intracranial aneurysm (biomarker_via_orthology) | 2.91e-03 | 13 | 185 | 2 | DOID:10941 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GNINQTGYFRVNYDL | 681 | Q9UKU6 | |
| SAYLYNNEEQVGLAI | 51 | P17516 | |
| ADEVYQDNVYAAGSQ | 271 | P24298 | |
| VYINILGGQYSDQAG | 501 | Q7L0X2 | |
| EYYNEEGLQNGEGQR | 306 | P16452 | |
| QLDYGIYVINQAGDT | 206 | P15291 | |
| IDAGADLNYVDVYGN | 126 | Q9BXX2 | |
| LVDQERGTGVYLFYN | 361 | Q9H7T0 | |
| NGLRYGDDYVVGQNV | 3181 | Q7Z407 | |
| DEGTNLGNVIDNYVY | 16 | O14977 | |
| AYGTRNNDELIQRNY | 1961 | Q86TB3 | |
| VINGTYDYTQLQGDT | 81 | Q92685 | |
| YGIVNGNTNQEFRID | 2191 | Q6V0I7 | |
| VELQGRGYDFTIQEN | 4356 | Q8WXG9 | |
| RGYDFTIQENGLQID | 4361 | Q8WXG9 | |
| DDVYGGTNRYFRQVA | 111 | P32929 | |
| EVVAIGTGEYNYSQD | 246 | Q96M93 | |
| VYTCNEGYQLLGEIN | 111 | P08603 | |
| QTYQQQYGRSLEDDI | 126 | P09525 | |
| NNYLYDGEEIATRGN | 141 | P19835 | |
| EQGYDVIAYLANIGQ | 26 | P00966 | |
| FYRDGVSEGQFQQVL | 666 | Q9UKV8 | |
| YEISLQEALAIYGGN | 361 | Q16853 | |
| NNLYAEAEKLGGQSY | 51 | Q7Z5G4 | |
| VITQIGLQDAGYYQC | 391 | Q8TDY8 | |
| AQQTDVYYQDPRGAA | 586 | Q5TC82 | |
| GRVADLTEQYNEQYG | 181 | Q9BWF3 | |
| TTGNVYAYEAVEQLN | 121 | Q13356 | |
| TQGLVYQGYLAANSR | 66 | Q56VL3 | |
| RVLLQGNEDYINASY | 686 | P26045 | |
| NLRIALRYYNQSEGG | 101 | P01893 | |
| QGIRNYHSGNDVEAY | 346 | Q9Y5A7 | |
| NGGISQTNTYDAQYE | 511 | Q8IZ07 | |
| LQLYDYQLEQEGTTG | 811 | Q9P260 | |
| DEGENGYVTYSIANL | 491 | Q14517 | |
| YNRIYEAGSENNTAV | 51 | Q9Y692 | |
| EEQDGRLATYSQLYQ | 171 | Q9GZV7 | |
| YTQAVDRLYREQGEN | 986 | Q86VF7 | |
| GEALRQVLVNRYYGN | 1741 | Q14643 | |
| RAAGKGYENEDNYAN | 251 | Q96EF0 | |
| SYYETFIQQGGDDVQ | 56 | Q15742 | |
| NQTDINVGYYTGDDR | 256 | P48051 | |
| QELRARYNLSQGGYE | 46 | O14649 | |
| NGEYSINYEGQNTVA | 96 | Q8WX39 | |
| YEIGYAADNSRTLNV | 11 | Q16206 | |
| QFAVGGQDQFVRIYD | 381 | P0C7V8 | |
| DIRYLLGYVSQQGGQ | 31 | Q9UK73 | |
| YNQEERVVCAGYDNG | 176 | Q96MX6 | |
| TVFAGNIGDNRYIVQ | 606 | Q10570 | |
| SLRNLRGYYNQSEDG | 101 | P10321 | |
| GKALYQVAYENEVGN | 276 | Q8NBM8 | |
| ILNGYEENSVVSYGQ | 316 | Q9H792 | |
| GGQVRQRYLYTDDAQ | 41 | Q9NSA1 | |
| QLKNTGDGDAYRLYN | 236 | Q8TET4 | |
| YAQLDVSYSGLVNDN | 171 | Q969I3 | |
| QEGYSEQGYLTREQS | 16 | Q9NRD0 | |
| LGLYNNQITDVGARY | 761 | Q9Y239 | |
| LYNDVYRASQGGVIS | 1581 | P09848 | |
| EAAERGNVYAQGNLV | 236 | Q9P2M1 | |
| TLEVRYAQVQDNGTY | 481 | Q96FE5 | |
| DYVAVFNGGEVNDAR | 211 | Q9UKZ9 | |
| SNYGNDRLGLYTFVN | 521 | Q9H3R1 | |
| VSNYGDGDIYNIVRN | 641 | Q6IE36 | |
| GRVADFTEQYNEQYG | 181 | Q9BQ04 | |
| YTGQIVLYSVNENGN | 461 | P17301 | |
| YRTQDGTAQGNRDYI | 1026 | P16144 | |
| RFEQLVNIGSSYNYG | 166 | Q8N5Z5 | |
| LGLYDTAGQEDYNQL | 71 | Q9H4E5 | |
| DREQYGQYALAVRGS | 226 | Q02413 | |
| AAYRQVQQRNELGVY | 41 | P46093 | |
| SRQGIEYILSNQGYV | 111 | Q27J81 | |
| QNTRNRINGKYYEIG | 371 | Q5SRI9 | |
| QEYQVGQLYSVAEAS | 16 | P48739 | |
| LGENFYVRQDGTRSY | 206 | Q8TCB7 | |
| SQLVRYAGYRQQDGS | 246 | P29474 | |
| INATGYYIFRGANSQ | 296 | O76062 | |
| RLVVQQAGQADAGEY | 946 | Q5VST9 | |
| NRDEGSYQVDQSRNY | 616 | P58401 | |
| NYQSYNDFVLRVGIN | 966 | Q08828 | |
| YLQGTNQITGRYEDG | 1526 | P04114 | |
| QAVYYLTLQATDGGN | 551 | Q9BYE9 | |
| NYDGDVQSDSVAQGY | 271 | O75874 | |
| NIYVTGGYRTDNIEA | 321 | Q8NBE8 | |
| FGQNEYLRYQEALSE | 171 | Q9BWL3 | |
| REGYTVQVNVNDYLD | 46 | P52797 | |
| YIRQGEQSLDGFYRA | 276 | Q9UK97 | |
| NGVIRGYQIGYRENS | 1016 | Q8TD84 | |
| GQTYNVDYVDAEGRV | 461 | Q8NCQ5 | |
| LGENDFINIIAYNDY | 321 | Q7Z3S7 | |
| QINGYRIVYNNADGT | 561 | Q05707 | |
| GGNQYFEYTTQRDLR | 531 | Q8NCL4 | |
| VQGYQRQLTYKRQDG | 1181 | Q8IZJ3 | |
| GLGGQVRYSLVNDYN | 966 | Q8TDW7 | |
| VGAEADQNYQNYILR | 156 | Q2V2M9 | |
| GNIISIQVENEYGSY | 176 | Q6UWU2 | |
| AARIAAEFYGVTQGQ | 51 | Q8WWX0 | |
| QTDRVDLGTLRGYYN | 96 | P04439 | |
| DNNGYVDVAVGAFRS | 441 | P13612 | |
| YGNSARVVYSILQGQ | 191 | Q13634 | |
| QQYEREYNNKRSGVG | 336 | O75899 | |
| RYRVVGSADAGQYNL | 71 | Q96J84 | |
| SEQFARYIDQQIQGG | 1546 | Q8IWT3 | |
| EAGQYNDNLYGTSVQ | 746 | Q15700 | |
| QAGRYTFVAGDQQSE | 521 | Q86VF2 | |
| RQEELGGAVYVYLNQ | 391 | Q13683 | |
| FYDLTQGTNLNRIGY | 1796 | Q6ZMW3 | |
| SGQAYYINDGESVNL | 271 | A6NKP2 | |
| VVYDGENFTGNQYVL | 1456 | Q9Y4K1 | |
| QYGSQVGYQIRFEST | 231 | Q14147 | |
| VQEDYGQDYILAQRN | 291 | P37059 | |
| AQLGAYAIQSELGDY | 136 | Q9HCS5 | |
| YEIQVAAYNGAGLGV | 841 | Q7Z5N4 | |
| AAANGILQGYRVVYE | 1826 | Q7Z5N4 | |
| NIYIREYSADNVDGN | 356 | Q16820 | |
| LGDQDVAFSYRQQTG | 566 | Q9Y2J2 | |
| EGLYTFQTQEGEQIY | 206 | Q8TEW6 | |
| IDYGDQYTARQLGSR | 76 | Q9Y5B8 | |
| VNGYIRIALYGSNEN | 371 | P54317 | |
| EGDTNSDYINGNYID | 946 | P28827 | |
| AYSNLGNVYKERGQL | 91 | O15294 | |
| EQLISIGSSYNYGNE | 211 | Q14681 | |
| GALLEREGYTFQQNA | 241 | O43364 | |
| RVTNQGAVDSLEYNY | 221 | Q10571 | |
| GDLQRQLYNRGEYNI | 26 | Q8TC56 | |
| GAINQEQASYDVSRY | 296 | A8MW99 | |
| QDIDSGQGIRNTYFE | 1056 | P11717 | |
| DYERNAGNLYTRQVQ | 61 | Q9BPW5 | |
| YSYIIQRNGGDGERN | 1881 | Q93008 | |
| FQAVYGLQRALQGDY | 111 | Q6UWJ1 | |
| DVYQYSGVQDAINIR | 1061 | Q8NDG6 | |
| NGNRRNYYIAAEEIS | 1576 | P12259 | |
| NGRIQVDQNSYGEFY | 406 | Q9Y6U3 | |
| QGRAENNCLYIEYGI | 1531 | Q5K651 | |
| GDRDGAQEVLTNYAY | 251 | Q15573 | |
| IYIRGEFYNEASNLQ | 156 | P49821 | |
| VNSNGYNLGVREDEV | 2446 | Q8NFP9 | |
| AAAQDVYYRDEIGNV | 286 | P04843 | |
| GYQRNTSQEEYLGGV | 726 | Q6AI14 | |
| GEQIYIFYGTRSNAE | 306 | Q86TU7 | |
| QQLLSTGRVQGYEGY | 2731 | Q9NT68 | |
| VYTGYGNREEQNLSD | 126 | Q16637 | |
| GVLYAVDSYNQRNAN | 681 | Q68BL8 | |
| DAGYYICTAQNLQGQ | 351 | Q15198 | |
| RGQIYDRQGATYLFD | 286 | O43463 | |
| VAYYELNNRVGETFQ | 276 | O15198 | |
| DVAQSTYDYGRQLLQ | 546 | Q86VW0 | |
| DYYNTRVVGALVDQG | 626 | Q66K14 | |
| GYEQRTTQQGQVYFL | 256 | Q9HAU4 | |
| YIYDLSNGEFVRGNE | 131 | Q12884 | |
| RQEYVLTQQGFIYQG | 156 | P21980 | |
| EETGDITQNYINYGT | 526 | Q9P2U8 | |
| VELGAYGQAVRYQGR | 191 | Q9UID3 | |
| YGQAVRYQGRAQAVL | 196 | Q9UID3 | |
| NASAVVLYNEERYGN | 131 | Q8NC42 | |
| NRYAVEGRDLTLQYN | 31 | P43308 | |
| EGRDLTLQYNIYNVG | 36 | P43308 | |
| YQELQGQRSDVYSDL | 91 | O43914 | |
| LVIGNLTNFEQGYYQ | 196 | Q86XK7 | |
| QNGQYKVENYLGSRD | 111 | P98170 | |
| GRYQYNTDVVFDSQG | 156 | O95497 | |
| NGEVVSAQGYEYDNL | 316 | Q9NXB0 | |
| VVYNYSAHGVQRDGE | 91 | H3BPM6 | |
| GYEVQITAANRLGYS | 661 | O15394 | |
| LRVYNNTARYVDQGG | 276 | P23921 | |
| DQIGGYGQLEAAYAQ | 216 | A0PJK1 | |
| RNVRQSGDVYYNTGD | 521 | Q9Y2P5 | |
| GYYSVQTTEGEQIAQ | 376 | Q9Y490 | |
| QRQEGFDNYLRLIYG | 861 | A6NE52 | |
| VEYQNKGRGNECVQY | 36 | Q9UHA2 | |
| GYLTESGYVNLQRVQ | 376 | Q9H0D6 | |
| GLYIQNVVQGDSGEY | 396 | Q92626 | |
| LEQRSGDITYGQFAQ | 201 | P19174 | |
| LLQDQVRNSYYIGAD | 1751 | Q6N022 | |
| QLRNSYQIGYDGSLR | 1691 | Q9P273 | |
| AEGYALYAQALTDQQ | 476 | O94826 | |
| NTNQGEYEREDNYGE | 706 | Q96N46 | |
| YRNVYTEQQTGDAVN | 481 | Q86WI1 | |
| YQFRTETNGGQVTYR | 66 | Q15853 | |
| DSEYRQFEGLQGYQE | 121 | O75290 | |
| VEYYTQQQGVLQDRD | 76 | P29350 | |
| VAYEQDGVIVSNDNY | 186 | A2A288 | |
| FQNIVDAYGVGSYRE | 376 | Q9HBG4 | |
| VQIDDSYYVDVGGSQ | 236 | Q8N895 | |
| CYRQGAYQEGVLLLN | 341 | Q8NEE8 | |
| EYQEEGQLLGQFTYD | 721 | O94901 | |
| NQEYLFVYGGRSVVE | 491 | O60294 | |
| IQEANVYGVAISGYE | 506 | Q9Y2P4 | |
| YAPRFVGYNQQDAQE | 346 | O75604 | |
| DIYQVQIAGNGQTYI | 601 | Q9Y4A5 | |
| IENAEIYNYLIGGNR | 736 | Q06418 | |
| YSNIYEQRGNEATEG | 516 | O95405 | |
| FQGIVDAYGVGRYQE | 371 | Q13488 | |
| GGNYAVELVNDSLYD | 271 | Q7Z7E8 | |
| RGGQYENFRVQYTET | 381 | Q86VM9 | |
| NIVDAYGVGSYREVN | 381 | Q9Y487 | |
| LYVLGGNDLDYNNDR | 496 | Q96NJ5 | |
| LIQAGYELNVQDYDG | 236 | O60237 |